Client Alerts & Insights
Mandatory Arbitration Agreements May Be in Jeopardy
March 18, 2022
Authored By:
A bill that would prohibit most pre-dispute mandatory arbitration agreements is one step closer to becoming law. The U.S. House of Representatives passed the Forced Arbitration Injustice Repeal Act (“FAIR Act”) yesterday behind a largely party-line vote.
The bill expands on another piece of legislation President Biden signed into law earlier this month that prohibits the forced arbitration of sexual assault and sexual harassment claims. While the earlier legislation, colloquially referred to as the #MeToo law, enjoyed bipartisan support in both chambers of Congress, it remains unclear whether the FAIR Act will enjoy similar support given its broad scope. It will next be considered by the U.S. Senate.
Should the bill become law, it would prohibit pre-dispute mandatory arbitration of claims (including class actions) that:
- Arise between consumers and sellers, as well as claims involving third parties related to such transactions;
- Relate to an actual or potential work relationship, including with respect to both employees and independent contractors;
- Allege violations of state or federal antitrust laws; or
- Allege violations of constitutional rights or anti-discrimination laws.
The bill would apply only to claims arising after its effective date and does not prohibit the voluntary use of arbitration after a dispute arises. It also provides an exemption for collective bargaining agreements. However, those agreements could not compel individual employees to waive the right to seek judicial enforcement of claims arising from the Constitution, a statute, or public policy.
Employers who use pre-dispute arbitration provisions in their form agreements should continue to monitor developments as this legislation moves to the Senate. We will provide updates as the legislation is considered by the Senate.
For more information, please contact a member of Benesch’s Labor & Employment Practice Group.
Adam Primm at aprimm@beneschlaw.com or 216.363.4451.
Latest News
Medical First, Recreational Later? DOJ’s Cannabis Order and the Stakes Ahead
DOJ’s April 2026 order immediately moved FDA-approved and state-licensed medical cannabis to Schedule III, removing harsh tax penalties for medical operators, while leaving adult-use cannabis under stricter Schedule I controls pending further administrative review.
New Sentencing Guidelines for Economic Crimes Effective November 1, 2026
In March we reported on the U.S. Sentencing Commission’s proposed amendments to the Federal Sentencing Guidelines (the “Guidelines”). On April 16, 2026, the bipartisan United States Sentencing Commission (the “Commission”) voted unanimously to adopt that package of amendments, without modification.
Judicial Green Light: Court Upholds NLRB’s Cemex Decision
On April 21st, 2026, the U.S. Court of Appeals for the Ninth Circuit upheld the National Labor Relations Board’s (“NLRB”) decision in Cemex Construction Materials Pacific, LLC., reinforcing a significant shift in federal labor law governing union recognition and employer conduct during organizing campaigns.
The LEAD Model—Kidney Care’s Value-Based Care Journey LEADs Here
The new LEAD Model, launching in 2027, is CMS’s next-generation value-based care framework for kidney care, integrating CKD and ESRD patients into standard ACOs with a 10-year benchmark period, new payment options and greater flexibility for nephrology-led organizations.